Think FDA Inspections Are Painful Now? These Could Be The Good Old Days
This article was originally published in The Rose Sheet
ICMAD's recent regulatory workshop offered perspective from FDA's Linda Katz and industry experts on the inspection process for cosmetics facilities under current law. It's clear that FDA inspections can be an ordeal, but that would pale in comparison to challenges that could arise under the proposed Personal Care Products Safety Act.
You may also be interested in...
Greenberg Traurig and Hogan Lovells attorneys provide first breakdowns of the game-changing Modernization of Cosmetic Regulations Act, including the potential for new lawsuits and plaintiff tactics.
It’s debatable the extent to which SB 1249, now headed to the governor’s desk, will improve animals’ lot, but cosmetic ingredient innovation is almost certain to suffer. Industry could escalate efforts behind alternative methods development, or there’s another possible solution: federal preemption.
ICMAD leadership agrees with Bailey that, now more than ever before, the pieces are in place for cosmetics reform legislation to reach the finish line. At the same time, the small-business advocate remains opposed to leading proposals, signaling the significant distance that negotiations may still have to go.